Psych Vivas · General adult psychiatry — personality disorders
Cluster A and C personality disorders — structured clinical viva
Fellowship viva covering schizotypal spectrum adjacency, OCPD vs OCD, dependent PD safeguarding, psychotherapy evidence including schema therapy, and limited pharmacotherapy.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
Case A — likely schizotypal PD. Cognitive-perceptual oddness, eccentric style, sparse friendships and paranoid-tinged social anxiety without frank psychosis fit schizotypal PD if enduring and impairing. Discriminate schizophrenia/delusional disorder (frank psychosis, deterioration), ASD (developmental communication profile), and paranoid PD (distrust without broader oddness). Monitor conversion risk; engage slowly; psychosocial strategies first; low-dose antipsychotic only as time-limited trial for severe cognitive-perceptual symptoms with low-certainty evidence and review dates; treat frank psychosis on a psychosis pathway.[1][4]
Case B — OCPD ± OCD. Separate ego-syntonic perfectionism/control from ego-dystonic obsessions/compulsions. Co-occurrence is common. ERP + SSRI algorithms treat OCD; CBT/schema strategies treat OCPD rigidity.[2][3]
Case C — dependent PD with safeguarding. Excessive need for care, fear of being left, and inability to leave a coercive relationship raise adult safeguarding duties, suicide risk after rupture, and therapy goals of graded autonomy without abrupt abandonment. Do not collude with exploitation.[5]
Cross-cutting. ICD-11 severity + traits; psychotherapy first-line (schema therapy RCT evidence for mixed PD including Cluster C); drugs for comorbidity/targets only; no nihilism.[2][5]
References5ShowHide
- [1]Kirchner SK, Roeh A, Nolden J, Hasan A Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review NPJ Schizophr, 2018.PMID 30282970
- [2]Bamelis LL, Evers SM, Spinhoven P, Arntz A Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders Am J Psychiatry, 2014.PMID 24322378
- [3]Pozza A, Starcevic V, Ferretti F, et al. Obsessive-Compulsive Personality Disorder Co-occurring in Individuals with Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis Harv Rev Psychiatry, 2021.PMID 33666394
- [4]Jakobsen KD, Skyum E, Hashemi N, et al. Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review J Psychopharmacol, 2017.PMID 28347257
- [5]Lampe L, Malhi GS Avoidant personality disorder: current insights Psychol Res Behav Manag, 2018.PMID 29563846